Michael Chudy

1.3k total citations
36 papers, 1.0k citations indexed

About

Michael Chudy is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Michael Chudy has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 22 papers in Epidemiology and 19 papers in Infectious Diseases. Recurrent topics in Michael Chudy's work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease Diagnosis and Treatment (7 papers). Michael Chudy is often cited by papers focused on Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease Diagnosis and Treatment (7 papers). Michael Chudy collaborates with scholars based in Germany, Austria and Italy. Michael Chudy's co-authors include C. Micha Nübling, Wolfram H. Gerlich, Julia Kreß, Johannes Löwer, M. Heiden, Markus B. Funk, Klaus‐Hinrich Heermann, R. Thomssen, Stephan Schaefer and Rainer Seitz and has published in prestigious journals such as Applied and Environmental Microbiology, Hepatology and Journal of Clinical Microbiology.

In The Last Decade

Michael Chudy

33 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Chudy Germany 19 711 668 362 113 110 36 1.0k
Francis Sarkodie United Kingdom 16 597 0.8× 531 0.8× 204 0.6× 104 0.9× 283 2.6× 23 979
Giulio Pisani Italy 19 402 0.6× 654 1.0× 593 1.6× 129 1.1× 26 0.2× 70 1.1k
Marco Koppelman Netherlands 21 372 0.5× 392 0.6× 606 1.7× 60 0.5× 37 0.3× 38 1.1k
M. K. Hourfar Germany 18 333 0.5× 237 0.4× 329 0.9× 110 1.0× 150 1.4× 26 827
Robin A. Gutierrez United States 14 653 0.9× 784 1.2× 267 0.7× 95 0.8× 10 0.1× 28 1.0k
Heinrich Scheiblauer Germany 12 469 0.7× 290 0.4× 221 0.6× 23 0.2× 32 0.3× 20 668
Â.R. Zanetti Italy 13 1.6k 2.2× 1.5k 2.2× 311 0.9× 25 0.2× 21 0.2× 41 1.8k
Britt Åkerlind Sweden 12 298 0.4× 103 0.2× 307 0.8× 77 0.7× 11 0.1× 21 640
AM Couroucé France 11 452 0.6× 400 0.6× 115 0.3× 8 0.1× 23 0.2× 30 589
Anna S. Nishiya Brazil 12 265 0.4× 190 0.3× 219 0.6× 129 1.1× 16 0.1× 40 505

Countries citing papers authored by Michael Chudy

Since Specialization
Citations

This map shows the geographic impact of Michael Chudy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chudy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chudy more than expected).

Fields of papers citing papers by Michael Chudy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Chudy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chudy. The network helps show where Michael Chudy may publish in the future.

Co-authorship network of co-authors of Michael Chudy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Chudy. A scholar is included among the top collaborators of Michael Chudy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Chudy. Michael Chudy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prax, Marcel, et al.. (2025). Implementation of a blood proficiency testing scheme for bacterial screening of platelet components. Vox Sanguinis. 120(4). 401–410.
2.
Stelzl, Evelyn, Sandra Ciesek, Markus Cornberg, et al.. (2021). Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study. Journal of Clinical Virology. 142. 104932–104932. 26 indexed citations
3.
Scheiblauer, Heinrich, M. Heiden, Markus B. Funk, et al.. (2020). Detection of hepatitis B virus infection in German blood donors 2008–2015. Vox Sanguinis. 115(3). 152–161. 4 indexed citations
4.
Golsaz‐Shirazi, Forough, Mohammad Mehdi Amiri, Mohammad Hojjat‐Farsangi, et al.. (2020). Immunoreactivity pattern of monoclonal antibodies against Hepatitis B vaccine with global Hepatitis B virus genotypes. Clinica Chimica Acta. 510. 203–210. 2 indexed citations
5.
Golsaz‐Shirazi, Forough, Mohammad Mehdi Amiri, Felix Bohne, et al.. (2017). Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg). Antiviral Research. 144. 153–163. 10 indexed citations
6.
Peiffer, Kai‐Henrik, Dieter Glebe, Andreas Reuter, et al.. (2016). Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes. Virology. 502. 1–12. 22 indexed citations
7.
Wilkinson, Dianna E., Pia L. Seiz, Christian G. Schüttler, et al.. (2016). International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen. Journal of Clinical Virology. 82. 173–180. 9 indexed citations
8.
Baylis, Sally A., Michael Chudy, & C. Micha Nübling. (2015). Standardization of NAT for Blood-Borne Pathogens. Transfusion Medicine and Hemotherapy. 42(4). 211–218. 10 indexed citations
9.
Peiffer, Kai‐Henrik, Kiyoshi Himmelsbach, Gert Carra, et al.. (2014). Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI level. Journal of Hepatology. 62(4). 791–798. 33 indexed citations
10.
Chudy, Michael, et al.. (2013). Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany. Transfusion Medicine and Hemotherapy. 41(1). 45–51. 15 indexed citations
11.
Chudy, Michael, Marijke Weber‐Schehl, Lutz Pichl, et al.. (2011). Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets. Transfusion. 52(2). 431–439. 34 indexed citations
12.
Nübling, C. Micha, M. Heiden, Michael Chudy, et al.. (2009). Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion. 49(9). 1850–1858. 53 indexed citations
13.
Blümel, Johannes, et al.. (2008). West Nile virus and blood product safety in Germany. Journal of Medical Virology. 80(3). 557–563. 19 indexed citations
14.
Chudy, Michael, et al.. (2008). Consistency of quantitation of HCV genotype 4 from egypt across three HCV‐RNA amplification assays. Journal of Medical Virology. 80(12). 2086–2091. 3 indexed citations
15.
Nübling, C. Micha, Michael Chudy, Peter Volkers, & Johannes Löwer. (2006). Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection. Transfusion. 46(11). 1886–1891. 19 indexed citations
16.
17.
Chudy, Michael, Indira Hewlett, J. Saldanha, et al.. (2003). Technical considerations for the performance of Nucleic acid Amplification Technology (NAT). Biologicals. 31(3). 153–159. 5 indexed citations
18.
Nübling, C. Micha, et al.. (2002). Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase. Transfusion. 42(8). 1037–1045. 77 indexed citations
19.
Chudy, Michael, Annemarie Berger, C. Micha Nübling, et al.. (2002). Hepatitis A Virus Infection in Tamarins: Experimental Transmission via Contaminated Factor VIII Concentrates. The Journal of Infectious Diseases. 185(8). 1170–1173. 5 indexed citations
20.
Chudy, Michael, et al.. (1999). A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool. Journal of Medical Virology. 57(2). 91–99. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Sarkodie Breakdown of academic impact, for papers by Giulio Pisani Breakdown of academic impact, for papers by Marco Koppelman Breakdown of academic impact, for papers by M. K. Hourfar Breakdown of academic impact, for papers by Robin A. Gutierrez Breakdown of academic impact, for papers by Heinrich Scheiblauer Breakdown of academic impact, for papers by Â.R. Zanetti Breakdown of academic impact, for papers by Britt Åkerlind Breakdown of academic impact, for papers by AM Couroucé Breakdown of academic impact, for papers by Anna S. Nishiya
Rankless by CCL
2026